Furthermore, we characterized the synthesized radiotracer in vitro and in vivo and assessed the efficacy of [18F]FB-IL-2 as an imaging biomarker in preclinical PET imaging of CD25+ TILs in syngeneic murine colon cancer models. This evidence concerns the gene IL2 and colonic neoplasm.